美女免费一级视频在线观看
MAHA report on US children targets food and drug marketing. The report called for stricter drug and consumer ad regulations. The report also includes recommendations on researching vaccine injuries. (STAT News)
Novartis is set to acquire Tourmaline Bio for $1.4 billion. Tourmaline Bio is currently developing a treatment for atherosclerotic cardiovascular disease (Wall Street Journal).
Eli Lilly is offering biotech startups access to its AI products in exchange for data. The aim of the initiative is to gather data and information about various therapeutic areas. (Endpoints News)
UnitedHealth said that it expects about 78% of its members to be enrolled in top rated Medicare plans next year, in line with expectations. Shares of the company rose at least 4.3% today as a result. (CNBC)
ICER, a pricing group in the U.S. said that weight loss drugs are becoming more cost-effective. The group rates semaglutide and tirzepatide as more cost-effective compared to lifestyle modifications. (Reuters)
To read yesterday’s edition of Five things for pharma marketers to know, click here.